186 related articles for article (PubMed ID: 20434034)
1. HLA-G and immune evasion in cancer cells.
Sheu J; Shih IeM
J Formos Med Assoc; 2010 Apr; 109(4):248-57. PubMed ID: 20434034
[TBL] [Abstract][Full Text] [Related]
2. Application of human leukocyte antigen-G expression in the diagnosis of human cancer.
Shih IeM
Hum Immunol; 2007 Apr; 68(4):272-6. PubMed ID: 17400063
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological significance of HLA-G expression in ovarian cancer.
Sheu JJ; Shih IeM
Semin Cancer Biol; 2007 Dec; 17(6):436-43. PubMed ID: 17681474
[TBL] [Abstract][Full Text] [Related]
4. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
5. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.
Agaugué S; Carosella ED; Rouas-Freiss N
Blood; 2011 Jun; 117(26):7021-31. PubMed ID: 21482709
[TBL] [Abstract][Full Text] [Related]
6. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
Yie SM; Hu Z
Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
[TBL] [Abstract][Full Text] [Related]
8. No expression of human leukocyte antigen G (HLA-G) in colorectal cancer cells.
Leelawat K; Engprasert S; Pongchai-rerk U; Tuchinda S; Suthipintawong C; Leardkamolkarn V
J Med Assoc Thai; 2004 Jul; 87(7):816-8. PubMed ID: 15521238
[TBL] [Abstract][Full Text] [Related]
9. [HLA-G: a tolerance molecule implicated in the escape of tumors from immunosurveillance].
Paul P; Rouas-Freiss N; Carosella ED
Pathol Biol (Paris); 1999 Oct; 47(8):766-70. PubMed ID: 10573693
[TBL] [Abstract][Full Text] [Related]
10. Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Wischhusen J; Waschbisch A; Wiendl H
Semin Cancer Biol; 2007 Dec; 17(6):459-68. PubMed ID: 17768067
[TBL] [Abstract][Full Text] [Related]
11. Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules.
Le Friec G; Gros F; Sebti Y; Guilloux V; Pangault C; Fauchet R; Amiot L
J Leukoc Biol; 2004 Dec; 76(6):1125-33. PubMed ID: 15331623
[TBL] [Abstract][Full Text] [Related]
12. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.
Carosella ED; Moreau P; Le Maoult J; Le Discorde M; Dausset J; Rouas-Freiss N
Adv Immunol; 2003; 81():199-252. PubMed ID: 14711057
[TBL] [Abstract][Full Text] [Related]
13. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
Rouas-Freiss N; Moreau P; Menier C; LeMaoult J; Carosella ED
Semin Cancer Biol; 2007 Dec; 17(6):413-21. PubMed ID: 17881247
[TBL] [Abstract][Full Text] [Related]
14. HLA-G and MIC expression in tumors and their role in anti-tumor immunity.
Seliger B; Abken H; Ferrone S
Trends Immunol; 2003 Feb; 24(2):82-7. PubMed ID: 12547505
[TBL] [Abstract][Full Text] [Related]
15. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
[TBL] [Abstract][Full Text] [Related]
16. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
17. Non-classical HLA-G antigen and its role in the cancer progression.
Tripathi P; Agrawal S
Cancer Invest; 2006 Mar; 24(2):178-86. PubMed ID: 16537188
[TBL] [Abstract][Full Text] [Related]
18. HLA-G and its KIR ligands in cancer--another enigma yet to be solved?
Urosevic M; Trojan A; Dummer R
J Pathol; 2002 Mar; 196(3):252-3. PubMed ID: 11857486
[TBL] [Abstract][Full Text] [Related]
19. HLA-G: A New Immune Checkpoint in Cancer?
Krijgsman D; Roelands J; Hendrickx W; Bedognetti D; Kuppen PJK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630545
[TBL] [Abstract][Full Text] [Related]
20. HLA-G in the skin--friend or foe?
Urosevic M
Semin Cancer Biol; 2007 Dec; 17(6):480-4. PubMed ID: 17981049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
